Indian Journal of Drugs in Dermatology

BRIEF REPORT
Year
: 2022  |  Volume : 8  |  Issue : 2  |  Page : 73--78

Platelet-rich plasma for the treatment of vitiligo: A case series


Prajul Mehta1, Ghanshyam Verma1, Geeta R Tegta1, Sakshi Bhota2 
1 Department of Dermatology, Venereology and Leprosy, Indira Gandhi Medical College, Shimla, India
2 Department of Community Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh, India

Correspondence Address:
Sakshi Bhota
Department of Community Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, Kangra, Himachal Pradesh
India

Vitiligo is a multifactorial disorder characterized by the loss of functional melanocytes. Even though not a life-threatening disorder, many suffer enormous stigma and psychiatric comorbidities. The treatment of vitiligo still remains a challenge. To get therapeutic success, there has been a continuous search for newer treatment modalities. We hereby report the case series of five patients of stable vitiligo who were resistant to topical therapies. These patients were given intradermal platelet-rich plasma at 4-week interval for a total of four injections. Out of five patients, two showed excellent response and two patients showed moderate response to the treatment, whereas there was no response seen in one patient.


How to cite this article:
Mehta P, Verma G, Tegta GR, Bhota S. Platelet-rich plasma for the treatment of vitiligo: A case series.Indian J Drugs Dermatol 2022;8:73-78


How to cite this URL:
Mehta P, Verma G, Tegta GR, Bhota S. Platelet-rich plasma for the treatment of vitiligo: A case series. Indian J Drugs Dermatol [serial online] 2022 [cited 2023 Feb 8 ];8:73-78
Available from: https://www.ijdd.in/article.asp?issn=2455-3972;year=2022;volume=8;issue=2;spage=73;epage=78;aulast=Mehta;type=0